• Skip to primary navigation
  • Skip to main content
DB-I Logo

DenseBreast-info, Inc.

Get Smart About Being Dense

HOME/USA

EUROPE

Español

  • Home
  • For Patients
    • Patients Home
    • Dense Breasts: 5 Facts You Should Know
    • Is My Mammogram Enough?
    • Screening Tests After a Mammogram (Table)
    • Let’s Talk About Dense Breasts, Video Series
    • Patient Questions and Answers
    • Patient Resources by Language
    • Print: Patient Fact Sheet
    • Print: Patient Brochure
  • For Providers
    • Providers Home
    • CME/CE: “Dense Breasts, Risk, and Supplemental Screening”
    • Flow Chart: Who Needs More Screening?
    • Health Care Provider FAQs
    • Risk Model Tutorial
    • Table: Mammography Guideline Comparison
    • Table: Dense Breast Screening Guidelines
    • Table: High/Increased-Risk Screening Guidelines
    • DBI Research
    • Patient Resources
  • Screening Technologies
    • Screening Technologies Home
    • For Patients: Screening Tests After a Mammogram (Table)
    • For Providers: Cancer Detection by Screening Method (Table)
    • 2D/3D Mammography
    • Mammography AI Screening Tools, Comparative Tables
    • Breast Ultrasound (Sonogram)
    • Breast MRI
    • Contrast-Enhanced Mammography (CEM)
    • Molecular Breast Imaging
    • DBI Research
  • Inform/Insurance Laws
    • Inform/Insurance Laws Home
    • Inform: Federal FDA Dense Breast Reporting
    • Insurance
      • State Law Insurance Map and Federal HRSA Guidelines
      • State Law Insurance Table
      • Federal Insurance Bill: Find It Early Act
  • Blog & Press
  • About Us
    • About Us Home
    • Our Mission
    • World Dense Breast Day
    • Our Team
    • DBI Research
    • Let’s Talk About Dense Breasts, Video Series
    • Patient Resources
    • Contact Us
    • Please Donate
  • Our Corporate and Health Group Supporters
/ Blog / We’re Reaching Patients and Providers—Everywhere
We’re Reaching Patients and Providers—Everywhere | Dense Breast Info

We’re Reaching Patients and Providers—Everywhere

February 23, 2026 by JoAnn Pushkin

Multi-lingual Patient Flyers

Our patient flyer, Why a Conversation About Your Breast Density Matters is available in over 30 languages and dialects. The one-page printable flyer is an ideal resource for clinics or health fairs. Share confidently, all DBI translated content is meticulously crafted by native speakers specializing in breast radiology.

 

Lecture: When is Screening Mammography Not Enough?

Dr. Wendie Berg and Dr. Philip Strax

DBI’s Chief Scientific Advisor, Dr. Wendie Berg, was honored to give the Philip Strax, MD Breast Imaging and Saving Lives Lecture for the Texas Radiological Society in Houston on February 14th, entitled “When is Screening Mammography Not Enough?” Dr. Strax is the radiologist who, together with statistician Sam Shapiro, led the pivotal and pioneering Health Insurance Plan of New York randomized trial of screening mammography in the 1960s.  Dr. Richard Strax, also a radiologist, has honored his father’s legacy with this lectureship. Dr. Daniel Kopans, Dr. Edward Sickles, and Dr. Debra Monticciolo are previous presenters.

Highlights from Dr. Berg’s presentation included:

  • Participation in screening is the biggest issue needing improvement, including identifying women at higher risk who should start screening earlier than age 40 (and usually with MRI).  To accomplish this, all women ideally should have risk assessment by age 25, especially those of Black, Hispanic, Asian, or Ashkenazi Jewish descent or with family history of breast or ovarian cancer.
  • Breast density, methods to assess risk, and supplemental screening options, with emphasis on when MRI is indicated, and gaps in current insurance coverage that would be addressed by the Find It Early Act.
  • The “flip side” of risk assessment of possibly reducing screening of women based on low risk, including the WISDOM trial results. Such approaches are limited by concerns that current methods (including AI) are inadequate to identify all women who will develop cancer in the next 2-5 years.
  • A look to the future may include liquid biopsy as a screening method, with the potential that breast imaging would become more focused on diagnostic imaging and biopsy

 

Newly Appointed

DBI’s European Educator and supporter for France, Professor Isabelle Thomassin-Naggara, MD, has been appointed as ESR Quality, Safety & Standards Committee (QSSC) Chair.  This is another distinguished appointment for Prof. Thomassin-Naggara, who also holds the post as Women’s Imaging Editor at the European Journal of Radiology. We extend our congratulations to, Isabelle!

DenseBreast‑info, Inc. is an independent, nonprofit organization. DBI is not affiliated with or endorsed by other organizations unless expressly identified. If you have questions about DBI’s programs or partnerships, please contact us.

© Unpublished, DenseBreast-info, Inc. ALL RIGHTS RESERVED | 501(c)(3) Public Charity

  • Online Privacy Policy
  • Online Terms of Use & Disclaimers

This website is for informational purposes only and is not intended to be a substitute for medical advice from a physician or to create a standard of care for health care providers. In addition, information has been provided by independent third parties and may not represent the views of DenseBreast-info.org. Please check with a physician regarding your specific condition, if you have any questions, or need a diagnosis. If you are experiencing an urgent medical condition, call your local emergency services [e.g., 9-1-1 (in the USA) or 1-1-2 (in Europe)].